Prothena Corp PLC
(FRA:0PT)
€
13.1
-1.2 (-8.39%)
Market Cap: 710.61 Mil
Enterprise Value: 220.07 Mil
PE Ratio: 0
PB Ratio: 1.38
GF Score: 64/100 Prothena Corporation PLC at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
May 19, 2021 / 12:35PM GMT
Release Date Price:
€19.2
(+5.49%)
Kennen MacKay
RBC Capital Markets,RBC Biotechnology Research - Managing Director
Hi, my name is Kennen MacKay, and I am pleased to kick off our next session with Prothena. From Prothena, we have Dr. Gene Kinney, the Chief Executive Officer as well as Tran Nguyen, the Chief Financial Officer. Gene, Tran, thanks so much for joining us this morning.
Gene Kinney
Prothena Corporation plc - President and CEO, Director
Well, thanks for having us, Kennen. Appreciate being here.
Tran Nguyen
Prothena Corporation plc - COO and CFO
Absolutely, thanks, Kennen.
Kennen MacKay
RBC Capital Markets,RBC Biotechnology Research - Managing Director
So I'd love to dive into the resurgence of not only amyloid but also Birtamimab and AL Amyloidosis. But before we jump in, just given the recent ADP meeting and the fact that yourselves and a huge portion of the team at Prothena are some of the world's experts on Alzheimer's, and maybe we can just start there. I'd love to hear your takeaways on
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot